BALA CYNWYD, Pa., April 16, 2013 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Life Technologies Corp. ("Life" or the "Company") (Nasdaq- LIFE-News) relating to the reported acquisition by Thermo Fisher Scientific, Inc. ("Thermo Fisher").
Under the terms of the transaction Life Shareholders will receive $76 in cash for each share of Life stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Life for not acting in the Company's shareholders' best interests in connection with the sale process. The market for gene tests, like the one sold by Life, may grow to $25 billion within a decade as more doctors use a patient's genetic makeup to tailor treatments.
If you own shares of Life stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at email@example.com visiting http://brodsky-smith.com/564-life-life-technologies-corp.html, by calling toll free 877-LEGAL-90.
Attorney advertising. Prior results do not guarantee a similar outcome.
SOURCE Brodsky & Smith, LLC